Bullboard - Stock Discussion Forum NRX Pharmaceuticals Inc NRXP

Financial Services Healthcare

NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing therapeutics based on its N-methyl-D-aspartate (NMDA) platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and post-traumatic stress disorder (PTSD). The Company has two lead compounds, NRX-100, a proprietary presentation of... see more

Add To Watchlist

NDAQ:NRXP - Post Discussion

NRX Pharmaceuticals Inc > Buying NRXP at 0.5 It still has $40mil cash in its treasury

View:

Post by flight100 on May 26, 2022 1:02pm

Buying NRXP at 0.5 It still has $40mil cash in its treasury

As per NRXP financial news, NRXP had $40 million cash as of March 31. So, current price 0.51 is steal and the stock price should move up very quickly.

As of March 31, 2022, cash was $40.2 million compared to $27.6 million as of December 31, 2021. NRx Pharmaceuticals believes it has sufficient cash to support operations for at least the next 12 months.

117